Clinical Trials Using Technetium Tc-99m Sulfur Colloid

Clinical trials are research studies that involve people. The clinical trials on this list are studying Technetium Tc-99m Sulfur Colloid. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trials 1-5 of 5
  • FLARE RT for Patients with Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET / CT and SPECT / CT Imaging

    This phase II trial studies how well positron emission tomography (PET) / computed tomography (CT) and single positron emission computed tomography (SPECT) / CT imaging works in improving radiation therapy treatment in patients with stage IIB-IIIB non-small cell lung cancer. PET / CT imaging mid-way through treatment may be able to accurately show how well radiation therapy and chemotherapy are working. SPECT / CT imaging may be able to tell which parts of the lung tissue are healthier than others. Based on the result of the imaging, treatment adjustments may be made to the radiation therapy to improve survival and decrease toxicity.
    Location: 2 locations

  • Sentinel Lymph Node Biopsy after Chemotherapy before Surgery in Identifying Residual Cancer Cells in Patients with Locally Advanced Breast Cancer

    This clinical trial studies how well sentinel lymph node biopsy after chemotherapy before surgery works in identifying residual cancer cells in patients with breast cancer that has spread from where it started to nearby tissue or lymph nodes (locally advanced). Sentinel lymph node biopsy is the removal and examination of the sentinel node(s) (the first lymph node[s] to which cancer cells are likely to spread from a primary tumor) and may help to allow patients with breast cancer to have fewer lymph nodes removed as part of their cancer care in the future.
    Location: 7 locations

  • Sulfur Colloid SPECT / CT in Measuring Liver Function in Patients with Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery

    This pilot trial studies how well single photon emission computed tomography (SPECT) / computed tomography (CT) with technetium Tc-99m sulfur colloid works in measuring liver function in patients with liver cancer that has or has not spread to other place in the body who are undergoing radiation therapy or surgery. Diagnostic procedures, such as sulfur colloid SPECT / CT scans, may measure normal liver tissue before, during and after treatment and help doctors plan better treatment for liver cancer patients.
    Location: 2 locations

  • Lymph Node Mapping in Finding Metastatic Disease in Patients with Sebaceous Gland Cancer of the Eyelid

    This phase II trial studies how well lymph node mapping works in finding disease that has spread from the place where it started to other places in the body in patients with sebaceous gland cancer of the eyelid. Lymph node mapping may help in planning surgery to remove cancer and affected lymph nodes.
    Location: M D Anderson Cancer Center, Houston, Texas

  • VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer

    The purpose of this Phase 1 portion of this clinical research study is to find out what dose of dilute fluorescein is needed for a surgeon to best see important lymph nodes that need to be removed during surgery (a standard of care surgery referred to as a Sentinel Lymph Node Biopsy procedure) in patients diagnosed with breast cancer. The purpose of the Phase 2 portion of this clinical research study is to find out if giving dilute fluorescein sodium in combination with a radiotracer (a drug that is radioactive) can help surgeons localize the lymph nodes that need to be removed in patients diagnosed by breast cancer.
    Location: See Clinical Trials.gov